HAART attack: metabolic disorders during long-term antiretroviral therapy.
David
E
E
D000273:Adipose Tissue / Q000378:metabolism*; D019380:Anti-HIV Agents / Q000009:adverse effects*; D000963:Antimetabolites / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D019247:HIV Wasting Syndrome / Q000209:etiology*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D017741:Survivors; D014481:United States
D019380:Anti-HIV Agents; D000963:Antimetabolites; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors